Energetic interventions for healthspan and resiliency with aging.
Several behavioral and pharmacological strategies improve longevity, which is indicative of delayed organismal aging, with the most effective interventions extending both life- and healthspan. In free living creatures, maintaining health and function into old age requires resilience against a multitude of stressors. Conversely, in experimental settings, conventional housing of rodents limits exposure to such challenges, thereby obscuring an accurate assessment of resilience. Caloric restriction (CR) and exercise, as well as pharmacologic strategies (resveratrol, rapamycin, metformin, senolytics), are well established to improve indices of health and aging, but some paradoxical effects have been observed on resilience. For instance, CR potently retards the onset of age-related diseases, and improves lifespan to a greater extent than exercise in a variety of models. However, exercise has proven more consistently beneficial to organismal resilience against a broad array of stressors, including infections, surgery, wound healing and frailty. CR can improve cellular stress defenses and protect from frailty, but also impairs the response to infections, bed rest and healing. How an intervention will impact not only longevity, health and function, but also resiliency, is critical to better understanding translational implications. Thus, organismal robustness represents a critical, albeit understudied aspect of aging, which needs more careful attention in order to better inform on how putative age-delaying strategies will impact preservation of health and function in response to stressors with aging in humans.
Department of Molecular Pharmacology and Medicine, Albert Einstein College of Medicine, Bronx, NY, USA; Institute for Aging Research, Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: derek.huffman@einstein.yu.edu.
Derek M
DM
Huffman
Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Marissa J
MJ
Schafer
Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA.
Nathan K
NK
LeBrasseur
D000375:Aging / Q000187:drug effects / Q000502:physiology*; D031204:Caloric Restriction / Q000379:methods*; D004032:Diet; D002149:Energy Intake / Q000502:physiology*; D015444:Exercise / Q000502:physiology; D005260:Female; D006801:Humans; D008136:Longevity / Q000502:physiology*; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D000077185:Resveratrol; D020123:Sirolimus / Q000627:therapeutic use; D013267:Stilbenes / Q000627:therapeutic use
D013267:Stilbenes; D008687:Metformin; D000077185:Resveratrol; D020123:Sirolimus
Aging; Caloric restriction; Diet; Exercise; Metformin; Rapamycin; Resiliency; Resveratrol; Robustness; Senolytics